| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1921527 | F | Antimelanogenic activity in Cryptococcus neoformans var. grubii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of L-dopa | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 2. | ALA1919686 | F | Antimelanogenic activity in Cryptococcus neoformans var. grubii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of dopamine | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 3. | ALA1919688 | F | Antimelanogenic activity in Cryptococcus neoformans var. grubii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of epinephrine | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 4. | ALA1919690 | F | Antimelanogenic activity in Cryptococcus neoformans var. gattii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of L-dopa | Cryptococcus gattii | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA1919692 | F | Antimelanogenic activity in Cryptococcus neoformans var. gattii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of dopamine | Cryptococcus gattii | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA1919694 | F | Antimelanogenic activity in Cryptococcus neoformans var. gattii assessed as halo diameter surrounded by non-melanized cells at 20 ug after 6 to 8 days by halo assay in presence of epinephrine | Cryptococcus gattii | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA1919697 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as inhibition of pigmentation at 0.8 ug/mL after 10 days by microtiter plate assay in presence of 1 mM catecholamine | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 8. | ALA1919700 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as inhibition of pigmentation at 0.8 ug/mL after 21 days by microtiter plate assay in presence of 1 mM catecholamine | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 9. | ALA1919701 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as onset day of melanization at 0.06 uM by drop test assay in presence of 1 mM L-dopa (Rvb = 6 days) | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 10. | ALA1919702 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as onset day of melanization at 0.2 uM by drop test assay in presence of 1 mM L-dopa (Rvb = 6 days) | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 11. | ALA1919985 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as onset day of melanization at 0.6 uM by drop test assay in presence of 1 mM L-dopa (Rvb = 6 days) | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 12. | ALA1919986 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as onset day of melanization at 2 uM by drop test assay in presence of 1 mM L-dopa (Rvb = 6 days) | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 13. | ALA1919987 | F | Antimelanogenic activity in non-melanized Cryptococcus neoformans var. grubii assessed as delay of melanization by drop test assay in presence of 1 mM L-dopa | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 14. | ALA1919988 | B | Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 100 uM epinephrine as substrate preincubated for 30 mins before substrate addition | Trametes versicolor | 2 | single protein format | Scientific Literature | ||
| 15. | ALA1919989 | B | Inhibition of laccase in Cryptococcus neoformans var. grubii assessed as production of dopachrome using 100 uM epinephrine as substrate preincubated for 30 mins before substrate addition | Cryptococcus neoformans var. grubii | 2 | assay format | Scientific Literature | ||
| 16. | ALA1919990 | B | Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 200 uM dopamine as substrate preincubated for 30 mins before substrate addition | Trametes versicolor | 2 | single protein format | Scientific Literature | ||
| 17. | ALA1919991 | B | Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 300 uM L-dopa as substrate preincubated for 30 mins before substrate addition | Trametes versicolor | 2 | single protein format | Scientific Literature | ||
| 18. | ALA1919992 | F | Antimelanogenic activity in Cryptococcus neoformans var. grubii assessed as halo diameter surrounded by non-melanized cells at 10 ug after 6 days by halo assay in presence of 1 mM L-dopa | Cryptococcus neoformans var. grubii | 1 | assay format | Scientific Literature | ||
| 19. | ALA1919994 | F | Antimelanogenic activity in Cryptococcus neoformans var. gattii assessed as halo diameter surrounded by non-melanized cells at 10 ug after 6 days by halo assay in presence of 1 mM L-dopa | Cryptococcus gattii | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA1919996 | B | Inhibition of DNA polymerase activity of HIV reverse transcriptase at 10 uM | Human immunodeficiency virus | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!